Target intelligence / Profile preview

Mediator of RNA polymerase II transcription subunit 14 (MED14)

Target
MED14
Molecular classification
Other (Mediator complex subunit, multiprotein coactivator complex), Transcription coactivator, Transcription coregulator
01

Overview

Mediator of RNA polymerase II transcription subunit 14 (MED14) is a large scaffolding protein that acts as a crucial architectural and functional backbone of the Mediator complex, an evolutionarily conserved multiprotein complex required for regulated transcription of nearly all RNA polymerase II-dependent genes. MED14 bridges the head, middle, and tail modules of the Mediator, facilitating structural integrity, and is critical for both basal and activator-dependent (e.g., p53) transcription. Its interaction with RNA polymerase II is essential for transcription initiation. MED14 also associates with general transcription factors, nuclear receptors, and certain cofactors including CRSP and thyroid hormone receptor complexes. Mutations or dysregulation of MED14 may have a role in cancer and other disorders of transcription, but it is not a direct therapeutic target, biomarker, or druggable protein as of current knowledge[1][2][4][6][7].

Other names
ARC150CRSP2CXorf4DRIP150EXLM1RGR1TRAP170CRSP complex subunit 2hRGR1CSRPActivator-recruited cofactor 150 kDa componentCofactor required for Sp1 transcriptional activation subunit 2RGR1 homologThyroid hormone receptor-associated protein complex 170 kDa componentTranscriptional coactivator CRSP150Vitamin D3 receptor-interacting protein complex 150 kDa component
02

Biological functions

Regulation of transcription by RNA polymerase IITranscription coactivationStructural backbone for Mediator complex assembly and integrityRecruitment and stabilization of interaction with general transcription factors and nuclear receptors
03

Disease associations

Cancer (implicated by involvement in global transcriptional regulation)Other (as global transcriptional regulator, potential involvement in a range of gene expression–related pathologies)
04

Safety considerations

Essentiality for global gene transcription (risk in targeting—global repression of core transcriptional machinery would be detrimental to cell viability)No current therapeutic targeting due to central cellular function
05

Interacting drugs

none known

Beyond the preview

Go deeper on Mediator of RNA polymerase II transcription subunit 14 (MED14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediator of RNA polymerase II transcription subunit 14 (MED14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call